Read user comments about the side effects, benefits, and effectiveness of Xtandi oral.
Overall User Ratings
20 Total User Reviews
User Reviews
Learn about
User Reviews
Reviewer: wagsk1, 55-64 on Treatment for 1 to less than 2 years (Patient)
Effectiveness
Ease of Use
Satisfaction
Comment:
entered the hospital because of a bad fall 12/2018. they found prostate cancer that was also in my bones and lymph nodes. psa was over 1000 while in the hospital. Started Xtandi 2 months later, with in 6 months my psa is now under1 and holding strong!
5
people
found this review helpful.
Was this review helpful? Yes | No
Reviewer: 65-74 Male on Treatment for 2 to less than 5 years (Patient)
Effectiveness
Ease of Use
Satisfaction
Comment:
7
people
found this review helpful.
Was this review helpful? Yes | No
Reviewer: Larry, 75 or over on Treatment for 6 months to less than 1 year (Patient)
Effectiveness
Ease of Use
Satisfaction
Comment:
I have been taking Xtandi for 7 months and so far my PSA had dropped and stayed low. For side effects I experience joint pain and it has slowed me some.
24
people
found this review helpful.
Was this review helpful? Yes | No
Reviewer: Tom in ArlingtonTX, 75 or over Male on Treatment for 1 to 6 months (Caregiver)
Effectiveness
Ease of Use
Satisfaction
Comment:
My father was placed on Xtandi 160mg daily beginning May 2, 2017. His most recent PSA from April 25, 2017 was 31.65. After two weeks on Xtandi, his PSA was 37.39. After two more weeks through June 1, his PSA was 54.56 so Xtandi appears to have accelerated his cancer as the tumor in his lung doubled in size from March 14 - June 2. This drug appears to have harmed my father. To make matters wor
...
Show Full Comment
20
people
found this review helpful.
Was this review helpful? Yes | No
Reviewer: Nigel S, 65-74 on Treatment for less than 1 month (Patient)
Effectiveness
Ease of Use
Satisfaction
Comment:
I am taking part in the Stampede clinical trial. Diagnosed with metastatic prostate cancer in September 2013. Joined the trial and along with the "normal" hormone treatment had 6 lots of intense radio therapy. PSA down to less then 1. November last year PSA had increased to 5.6 which is trigger point on the Stampede trial for additional treatment. Start Xtandi early January and PSA down
...
Show Full Comment
24
people
found this review helpful.
Was this review helpful? Yes | No
Ask the pharmacist
Questions about medications? Get expert answers by video or live chat about allergies, pregnancy, sleep, and more.
See the Ask the Pharmacist event schedule.
WebMD the app
Get trusted health information. Whenever. Wherever... with your iPhone, iPad or Android.
Find Out MoreIMPORTANT: About This Section and Other User-Generated Content on WebMD
The opinions expressed in WebMD User-generated content areas like communities, reviews, ratings, or blogs are solely those of the User, who may or may not have medical or scientific training. These opinions do not represent the opinions of WebMD. User-generated content areas are not reviewed by a WebMD physician or any member of the WebMD editorial staff for accuracy, balance, objectivity, or any other reason except for compliance with our Terms and Conditions. Some of these opinions may contain information about treatment or uses of drug products that have not been approved by the U.S. Food and Drug Administration. WebMD does not endorse any specific product, service, or treatment.
Do not consider WebMD User-generated content as medical advice. Never delay or disregard seeking professional medical advice from your doctor or other qualified healthcare provider because of something you have read on WebMD. You should always speak with your doctor before you start, stop, or change any prescribed part of your care plan or treatment. WebMD understands that reading individual, real-life experiences can be a helpful resource but it is never a substitute for professional medical advice, diagnosis, or treatment from a qualified health care provider. If you think you may have a medical emergency, call your doctor or dial 911 immediately.